Around age 50, the brain's memory center begins swapping out its longtime immune cells for more inflammatory ones, according to a new study—a discovery that may explain how normal aging paves the way for dementia, especially its most talked about form, Alzheimer's disease.

"Honestly, this surprised me," Furhan Qureshi, a board-certified internal medicine physician, told Newsweek. "We were taught in med school that brain's main immune cells tracked in the study are lifers—they show up before you're born and stay with you, renewing themselves in the brain.

"This study says that around 50, the hippocampus starts swapping them out for more inflammatory cells, possibly ones coming in from the blood. That's not a small tweak to the model. That's a rewrite."

Qureshi added that the findings could reshape how scientists think about the roots of diseases like Alzheimer's.

"We've known for years that inflammation is all over Alzheimer's brains—what we didn't know is where it starts," he said. "This suggests it may just be part of normal aging, kicking off in midlife, long before anyone has symptoms.

"The brain's immune environment is quietly changing under the surface for decades first."

What the Study Found

The research, funded by the National Institutes of Health, examined the hippocampus, the brain region responsible for learning and memory. Pulling together scientists from the University of California, San Diego, the New York Genome Center and the University of California, Irvine, researchers studied postmortem hippocampal tissue from 40 neurologically healthy adults, aged 20 to 95, using advanced single-cell techniques.

They found that microglia, the brain's primary immune cells, steadily decline between roughly age 50 and 75, and that as they disappear, they are replaced by cells carrying stronger inflammatory signals and traits resembling monocytes, immune cells that normally circulate in the blood rather than the brain.

That finding upends the long-held assumption that microglia form during embryonic development, and researchers had generally believed they stay in the brain for life, continually renewing themselves rather than being replaced by outside cells.

Researchers detected this shift by pairing standard gene-activity measurements with newer tools that map the genome's three-dimensional structure and its chemical modifications, known as the epigenome. That combination revealed changes in cell identity and origin that gene activity alone would have missed.

The study also found early signs of decline in cells that help maintain the blood-brain barrier, the protective boundary controlling what passes from the bloodstream into the brain.

What This Means for You

Aging is the single strongest risk factor for neurodegenerative disease, and the hippocampus is especially vulnerable to it. Researchers estimate that around 42 percent of Americans over age 55 will eventually develop a form of dementia.

The researchers noted that while prior studies had linked aging to increased inflammatory gene activity, gene expression alone offered an incomplete picture of what was driving the decline.

Ankit Chawla, a physician specializing in longevity and functional medicine, said the findings track with what his field has already observed.

"From a longevity perspective, the immune system is a key sentinel in the fundamental processes that drive aging, not least in the brain," Chawla told Newsweek. "It is not surprising that this study shows this to be a factor in the aging brain."

The study also found that aging weakens the genome's overall 3D organization across brain cell types, alongside a marked loss of astrocytes, another key cell type that works to support brain signaling and metabolism.

Newsweek reached out to the study's authors via email for more information.

Reference

Zemke, N. R., et al. (2026). Epigenetic and 3D genome reprogramming during the aging of the human hippocampus. Science. https://doi.org/10.1126/science.adt8307.

Contact Newsweek editors on this story: Kara Dolman and Emma Lee-Sang